BOSTON ADVANCE
RegisteredUS US · App #74613983 · Reg #1942628
Owned by
BAUSCH & LOMB INCORPORATEDApplication date
1994-12-20
Registration date
1995-12-19
Published date
1995-09-26
First use date
1989-08-25
Renewal date
2025-12-19
Expiry date
—
Kind of mark
Trademark
Mark feature
Word
NICE Classes
5Pharmaceuticals
Domestic Classes
Jurisdiction-specific classifications outside WIPO 1-45 (e.g. US old classes).
006018044046051052
Current owners
Applicants
- Wilmington Partners L.P.
Previous owners
- POLYMER TECHNOLOGY(U.S.A.) CORPORATION
- Wilmington Partners L.P.
- Wilmington Partners L.P.
- Wilmington Partners L.P.
Correspondence
- [Nancy L. Rowe] Bausch + Lomb
Activity Summary
Oppositions
0
P 0 · D 0
Assignments
30
Security: 8
Renewals
3
Prosecution events
72
Renewals & Maintenance
| Kind | Effective date | Status |
|---|---|---|
| Earliest Filing Date | 2034-12-19 | — |
| Latest Filing Date Without Additional Fee | 2035-12-19 | — |
| Latest Filing Date With Additional Fee | 2036-06-20 | — |
Assignments & Security Interests
| Date | Conveyance | Assignor → Assignee | Type |
|---|---|---|---|
| 2025-11-07 | RELEASE OF SECURITY INTEREST IN TRADEMARKS AT REEL/FRAME 6280/0211 | THE BANK OF NEW YORK MELLON → ATON PHARMA, INC., CORIA LABORATORIES, LLC, ORAPHARMA, INC., BAUSCH & LOMB INCORPORATED, VALEANT PHARMACEUTICALS IRELAND LIMITED, ECR PHARMACEUTICAL CO., INC., TECHNOLAS PERFECT VISION GMBH, COMMONWEALTH LABORATORIES, LTD., VALEANT CANADA LP, OCEANSIDE PHARMACEUTICALS, INC., VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L., DOW PHARMACEUTICAL SCIENCES, INC., ALDEN OPTICAL LABORATORIES, INC., SANTARUS, INC, SOLTA MEDICAL, INC., VALEANT PHARMACEUTICALS INTERNATIONAL, PRECISION DERMATOLOGY, INC., PRIVATE FORMULA CORP., INKINE PHARMACEUTICAL COMPANY, INC.., BAUSCH & LOMB PHARMA HOLDINGS CORP., VALEANT PHARMA POLAND SP. Z.O.O., VALEANT PHARMACEUTICALS NORTH AMERICA LLC, LABORATOIRE CHAUVIN S.A.S., VALEANT PHARMACEUTICALS INTERNATIONAL, INC., SALIX PHARMACEUTICALS, INC., ONPHARMA INC., SALIX PHARMACEUTICALS, LTD., UCYCLYD PHARMA, INC., MEDICIS PHARMACEUTICAL CORPORATION | Release |
| 2025-08-13 | ASSIGNMENT OF SECURITY INTEREST IN TRADEMARKS PREVIOUSLY RECORDED AT REEL/FRAME (7717/0577) | CITIBANK, N.A., AS RESIGNING AGENT → JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT | Security |
| 2025-06-26 | TRADEMARK SECURITY AGREEMENT | BAUSCH & LOMB INCORPORATED, ALDEN OPTICAL LABORATORIES, INC., BAUSCH + LOMB IRELAND LIMITED → CITIBANK, N.A., AS NOTES COLLATERAL AGENT | Transfer |
| 2025-04-08 | RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY AT REEL/FRAME NO. 5102/0628 | BARCLAYS BANK PLC, AS SUCCESSOR AGENT → BAUSCH & LOMB INCORPORATED | Release |
| 2025-04-08 | RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY AT REEL/FRAME NO. 6280/0114 | BARCLAYS BANK PLC → ATON PHARMA, INC., ORAPHARMA, INC., BAUSCH & LOMB INCORPORATED, BAUSCH + LOMB IRELAND LIMITED, COMMONWEALTH LABORATORIES, LLC, VALEANT PHARMACEUTICALS IRELAND LIMITED, VALEANT PHARMACEUTICALS IRELAND, INKINE PHARMACEUTICAL COMPANY, INC., TECHNOLAS PERFECT VISION GMBH, VALEANT PHARMACEUTICALS NORTH AMERICA, OCEANSIDE PHARMACEUTICALS, INC., PRIVATE FORMULA CORPORATION, BAUSCH HEALTH IRELAND LIMITED, ALDEN OPTICAL LABORATORIES, INC., SOLTA MEDICAL, INC., VALEANT PHARMACEUTICALS INTERNATIONAL, PRECISION DERMATOLOGY, INC., EXZELL PHARMA INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC, CORIA LABORATORIES, LTD., VALEANT PHARMACEUTICALS INTERNATIONAL, INC., SANTARUS, INC., SALIX PHARMACEUTICALS, INC., BAUSCH HEALTH COMPANIES INC., VALEANT PHARMA POLAND SP. ZO.O., VALEANT INTERNATIONAL (BARBADOS) SRL, SALIX PHARMACEUTICALS, LTD., BAUSCH HEALTH US, LLC, UCYCLYD PHARMA, INC., MEDICIS PHARMACEUTICAL CORPORATION, VALEANT PHARMACEUTICALS LUXEMBOURG S.A.R.L., ONPHARMA INC. | Release |
| 2023-09-29 | TRADEMARK SECURITY AGREEMENT | BAUSCH & LOMB INCORPORATED, ALDEN OPTICAL LABORATORIES, INC. → CITIBANK, N.A., AS NOTES COLLATERAL AGENT | Transfer |
| 2022-10-21 | RELEASE OF SECURITY INTEREST IN SPECIFIED TRADEMARKS (REEL/FRAME 5439/0392) | BARCLAYS BANK PLC → BAUSCH & LOMB INCORPORATED, BAUSCH + LOMB IRELAND LIMITED | Release |
| 2022-10-21 | RELEASE OF SECURITY INTEREST IN SPECIFIED TRADEMARKS (REEL/FRAME 6280/0114) | BARCLAYS BANK PLC → BAUSCH + LOMB IRELAND LIMITED, BAUSCH & LOMB INCORPORATED, ALDEN OPTICAL LABORATORIES, INC. | Release |
| 2022-10-18 | OMNIBUS TRADEMARK SECURITY RELEASE AGREEMENT (REEL/FRAME 7320/0509) | THE BANK OF NEW YORK MELLON → BAUSCH & LOMB INCORPORATED, ALDEN OPTICAL LABORATORIES, INC. | Release |
| 2022-10-18 | OMNIBUS TRADEMARK SECURITY RELEASE AGREEMENT (REEL/FRAME 6111/0139) | THE BANK OF NEW YORK MELLON → BAUSCH & LOMB INCORPORATED | Release |
| 2022-10-18 | OMNIBUS TRADEMARK SECURITY RELEASE AGREEMENT (REEL/FRAME 6280/0211) | THE BANK OF NEW YORK MELLON → BAUSCH + LOMB IRELAND LIMITED, BAUSCH & LOMB INCORPORATED, ALDEN OPTICAL LABORATORIES, INC. | Release |
| 2022-10-18 | OMNIBUS TRADEMARK SECURITY RELEASE AGREEMENT (REEL/FRAME 7630/0605) | THE BANK OF NEW YORK MELLON → BAUSCH & LOMB INCORPORATED, ALDEN OPTICAL LABORATORIES, INC. | Release |
| 2022-10-18 | OMNIBUS TRADEMARK SECURITY RELEASE AGREEMENT (REEL/FRAME 6586/0877) | THE BANK OF NEW YORK MELLON → BAUSCH + LOMB IRELAND LIMITED, BAUSCH & LOMB INCORPORATED, ALDEN OPTICAL LABORATORIES, INC. | Release |
| 2022-05-10 | TRADEMARK SECURITY AGREEMENT | BAUSCH & LOMB INCORPORATED, ALDEN OPTICAL LABORATORIES, INC. → CITIBANK, N.A. AS COLLATERAL AGENT | Transfer |
| 2022-02-10 | SECURITY AGREEMENT | ALDEN OPTICAL LABORATORIES, INC., BAUSCH & LOMB INCORPORATED, BAUSCH HEALTH US, LLC, MEDICIS PHARMACEUTICAL CORPORATION, OCEANSIDE PHARMACEUTICALS, INC., ORAPHARMA, INC., PRECISION DERMATOLOGY, INC., SALIX PHARMACEUTICALS, INC., SANTARUS, INC., SOLTA MEDICAL, INC., SALIX PHARMACEUTICALS, LTD., BAUSCH HEALTH AMERICAS, INC. → THE BANK OF NEW YORK MELLON | Transfer |
| 2021-06-08 | SECURITY INTEREST | ALDEN OPTICAL LABORATORIES, INC., BAUSCH & LOMB INCORPORATED, BAUSCH HEALTH US, LLC, MEDICIS PHARMACEUTICAL CORPORATION, OCEANSIDE PHARMACEUTICALS, INC., ORAPHARMA, INC., PRECISION DERMATOLOGY, INC., SALIX PHARMACEUTICALS, INC., SANTARUS, INC., SOLTA MEDICAL, INC., SALIX PHARMACEUTICALS, LTD., BAUSCH HEALTH AMERICAS, INC. → THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT | Security |
| 2019-03-08 | CORRECTIVE ASSIGNMENT TO CORRECT THE REGISTRATION NUMBERS PREVIOUSLY RECORDED AT REEL: 006586 FRAME: 0877. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. | ALDEN OPTICAL LABORATORIES, INC., BAUSCH & LOMB INCORPORATED, BAUSCH HEALTH AMERICAS, INC., MEDICIS PHARMACEUTICAL CORPORATION, OCEANSIDE PHARMACEUTICALS, INC., ORAPHARMA, INC., PRECISION DERMATOLOGY, INC., SALIX PHARMACEUTICALS, LTD., SALIX PHARMACEUTICALS, INC., PRIVATE FORMULA CORP., BAUSCH HEALTH US, LLC, SANTARUS, INC., SOLTA MEDICAL, INC. → THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT | Security |
| 2019-03-08 | SECURITY INTEREST | ALDEN OPTICAL LABORATORIES, INC., BAUSCH & LOMB INCORPORATED, BAUSCH HEALTH AMERICAS, INC., BAUSCH HEALTH US, LLC, MEDICIS PHARMACEUTICAL CORPORATION, OCEANSIDE PHARMACEUTICALS, INC., ORAPHARMA, INC., PRECISION DERMATOLOGY, INC., SALIX PHARMACEUTICALS, LTD., SALIX PHARMACEUTICALS, INC., SANTARUS, INC., SOLTA MEDICAL, INC., PRIVATE FORMULA CORP. → THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT | Security |
| 2018-02-13 | SECURITY INTEREST | ALDEN OPTICAL LABORATORIES, INC., ATON PHARMA, INC., BAUSCH & LOMB INCORPORATED, BAUSCH & LOMB PHARMA HOLDINGS CORP., COMMONWEALTH LABORATORIES, LLC, CORIA LABORATORIES, LTD., DOW PHARMACEUTICAL SCIENCES, INC., ECR PHARMACEUTICALS CO., INC., INKINE PHARMACEUTICAL COMPANY, INC., LABORATOIRE CHAUVIN S.A.S., MEDICIS PHARMACEUTICAL CORPORATION, OCEANSIDE PHARMACEUTICALS, INC., ONPHARMA INC., ORAPHARMA, INC., PRECISION DERMATOLOGY, INC., PRIVATE FORMULA CORP., SALIX PHARMACEUTICALS, LTD., SALIX PHARMACEUTICALS, INC., SANTARUS, INC., SOLTA MEDICAL, INC., TECHNOLAS PERFECT VISION GMBH, UCYCLYD PHARMA, INC., VALEANT CANADA LP, VALEANT PHARMACEUTICALS INTERNATIONAL, VALEANT PHARMACEUTICALS INTERNATIONAL, INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC, VALEANT PHARMA POLAND SP. Z O.O., VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L., VALEANT PHARMACEUTICALS IRELAND LIMITED → THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT | Security |
| 2018-02-13 | SECURITY INTEREST | ALDEN OPTICAL LABORATORIES, INC., ATON PHARMA, INC., BAUSCH & LOMB INCORPORATED, BAUSCH & LOMB PHARMA HOLDINGS CORP., COMMONWEALTH LABORATORIES, LLC, CORIA LABORATORIES, LTD., DOW PHARMACEUTICAL SCIENCES, INC., ECR PHARMACEUTICALS CO., INC., INKINE PHARMACEUTICAL COMPANY, INC., LABORATOIRE CHAUVIN S.A.S., MEDICIS PHARMACEUTICAL CORPORATION, OCEANSIDE PHARMACEUTICALS, INC., ONPHARMA INC., ORAPHARMA, INC., PRECISION DERMATOLOGY, INC., PRIVATE FORMULA CORP., SALIX PHARMACEUTICALS, LTD., SALIX PHARMACEUTICALS, INC., SANTARUS, INC., SOLTA MEDICAL, INC., TECHNOLAS PERFECT VISION GMBH, UCYCLYD PHARMA, INC., VALEANT CANADA LP, VALEANT PHARMACEUTICALS INTERNATIONAL, VALEANT PHARMACEUTICALS INTERNATIONAL, INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC, VALEANT PHARMA POLAND SP. Z O.O., VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L., VALEANT PHARMACEUTICALS IRELAND LIMITED → BARCLAY'S BANK PLC, AS COLLATERAL AGENT | Security |
| 2017-07-17 | SECURITY INTEREST | BAUSCH & LOMB INCORPORATED → THE BANK OF NEW YORK MELLON | Security |
| 2015-01-08 | NOTICE OF SUCCESSION OF AGENCY | GOLDMAN SACHS LENDING PARTNERS, LLC → BARCLAYS BANK PLC, AS SUCCESSOR AGENT | Transfer |
| 2013-08-30 | SECURITY INTEREST | BAUSCH & LOMB INCORPORATED → GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT | Security |
| 2013-08-05 | RELEASE OF SECURITY INTEREST | CITIBANK, N.A. AS ADMINISTRATIVE AGENT → WP PRISM INC. (N/K/A BAUSCH & LOMB HOLDINGS, INC.), BAUSCH & LOMB INCORPORATED, ISTA PHARMACEUTICALS | Release |
| 2012-05-18 | SECURITY AGREEMENT | BAUSCH & LOMB INCORPORATED → CITIBANK N.A., AS ADMINISTRATIVE AGENT | Transfer |
| 2012-05-18 | RELEASE OF SECURITY INTEREST | CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH → BAUSCH & LOMB INCORPORATED | Release |
| 2007-10-26 | SECURITY AGREEMENT | BAUSCH & LOMB INCORPORATED, B&L CRL INC., B&L CRL PARTNERS L.P., B & L DOMESTIC HOLDINGS CORP., B&L FINANCIAL HOLDINGS CORP., B&L SPAF INC., B&L VPLEX HOLDINGS, INC., BAUSCH & LOMB CHINA, INC., BAUSCH & LOMB INTERNATIONAL INC., BAUSCH & LOMB REALTY CORPORATION, BAUSCH & LOMB SOUTH ASIA, INC., BAUSCH & LOMB TECHNOLOGY CORPORATION, IOLAB CORPORATION, RHC HOLDINGS, INC., SIGHT SAVERS, INC., WILMINGTON MANAGEMENT CORP., WILMINGTON PARTNERS L.P., B&L MINORITY DUTCH HOLDINGS LLC → CREDIT SUISSE | Transfer |
| 2002-12-28 | MERGER | POLYMER TECHNOLOGY (USA) CORPORATION → BAUSCH & LOMB INCORPORATED | Transfer |
| 2000-08-21 | CHANGE OF NAME | B&L INTERNATIONAL HOLDINGS CORP. → POLYMER TECHNOLOGY (U.S.A.) CORPORATION | Transfer |
| 1999-06-04 | ASSIGNS THE ENTIRE INTEREST | WILMINGTON PARTNERS L.P. → B+L INTERNATIONAL HOLDINGS CORP. | Transfer |
Prosecution History
72 events| Date | Event |
|---|---|
| 2026-02-20 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
| 2026-02-20 | REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS) |
| 2026-02-20 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
| 2026-02-20 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 2026-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2026-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2026-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2026-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2026-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2026-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2026-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2026-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2026-02-11 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2025-11-20 | TEAS SECTION 8 & 9 RECEIVED |
| 2025-09-10 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2025-07-25 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2025-04-16 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2024-12-19 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| 2023-10-11 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2022-12-28 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2022-12-21 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2022-12-14 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2022-10-10 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 2022-10-10 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2022-10-10 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2022-10-10 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2022-10-10 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 2022-06-23 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2022-05-25 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2022-03-09 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2021-10-16 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2021-10-16 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2021-10-16 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2020-11-25 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2020-09-10 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 2020-09-10 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2020-09-10 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2020-09-10 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2020-09-10 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 2020-05-03 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2020-05-03 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2020-05-03 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2017-09-19 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2017-09-19 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2016-03-25 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
| 2016-03-25 | REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) |
| 2016-03-25 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
| 2016-03-25 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 2016-01-19 | TEAS SECTION 8 & 9 RECEIVED |
| 2016-01-19 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Showing first 50 of 72 events